COMP <GO>
TIL vs IMA // EV/EBITDA & P/E VALUATION
Instil Bio Inc. (NASDAQ) VS. ImageneBio Inc. (NASDAQ) • 15-METRIC TALLY: TIL 3
— IMA 0
■ METRIC PARITY
LAST: $6.83 (+0.52%) • MKT CAP: $46.3M
valuation
—
LAST: $4.05 (-3.57%) • MKT CAP: $46.0M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TIL VS. IMA)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TIL | IMA | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | -60.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -65.00% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | 0.20 | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 3/9 | 1/9 | +2.00 | TIL | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.4 | 40.3 | +16.13 | TIL | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $46.3M | $46.0M | $313.6K | TIL | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TIL REV | IMA REV | TIL GROSS % | IMA GROSS % | TIL FCF | IMA FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $800.0K | — | — | -$36.6M | -$47.8M |
| FY 2024 | $0 | $3.5M | — | — | -$55.7M | -$21.3M |
| FY 2023 | $0 | $9.2M | — | — | -$82.0M | -$79.7M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TIL // BETA —
IMA // BETA —